The prospect of approved and commercially available phage therapeutics

Harald König

Open source

DOI: 10.1016/j.ijantimicag.2025.107612
Published: 2025-12
Container: International Journal of Antimicrobial Agents
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijantimicag.2025.107612,
  title = {The prospect of approved and commercially available phage therapeutics},
  author = {Harald König},
  year = {2025},
  journal = {International Journal of Antimicrobial Agents},
  doi = {10.1016/j.ijantimicag.2025.107612},
  url = {https://doi.org/10.1016/j.ijantimicag.2025.107612}
}

RIS

TY  - JOUR
TI  - The prospect of approved and commercially available phage therapeutics
AU  - Harald König
PY  - 2025
JO  - International Journal of Antimicrobial Agents
DO  - 10.1016/j.ijantimicag.2025.107612
UR  - https://doi.org/10.1016/j.ijantimicag.2025.107612
ER  -

APA

König, H. (2025). The prospect of approved and commercially available phage therapeutics. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2025.107612

Source records

crossref · retrieved 2026-11-07T22:31:28.525Z